HOLLY HENDERSHOT: Open Payments
NPI 1083366397 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 29 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $311 |
| ABBVIE INC. | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Tris Pharma Inc | 2 | $37 |
| Corium, LLC | 2 | $32 |
| Noven Therapeutics, LLC | 1 | $21 |
| Alkermes, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Auvelity, Azstarys, Dyanavel XR, ABILIFY ASIMTUFII, Xelstrym.
Industry payments across MI — which companies pay providers there.
